And one organization, unfortunately, which is AARP, that is supposed to be looking out for seniors and lobbying on their behalf, is really conflicted, because they have a partnership with one of the three large PBMs, pharmacy benefit management companies, to promote their senior drug program
Gallbladder Disease: A meta-analysis of GLP-1 research identified an elevated risk of gallbladder and biliary disorders among users of these medications, particularly at higher doses and with prolonged use
34 Initial dosing regimen of Byetta is 5 g subcutaneously twice daily and after one month, the dose is increased to 10 g twice daily based on clinical response (Table 1)
Those prescribed GLP-1-RAs received education on smaller meal portions from their endocrinologist
At the same time, improvements in inflammatory markers and oxidative stress may further support vascular health
This keeps meals predictable while reducing boredom